总时间（秒）：40.18
问答时间（秒）：36.81

{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "DJ-1",
                "Protein_Change": {
                    "ref": "P",
                    "alt": "A",
                    "position": "149"
                },
                "variant_string_id": "DJ-1 P149A"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper discusses the loss of function of DJ-1 in Parkinson’s disease due to proteolytic resistance to caspase-6.",
                    "judgment": "Yes",
                    "reasoning": "DJ-1 is a gene product responsible for a subset of familial PD, and the mechanisms by which mutations alter its function and account for PD-related pathology are investigated."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The paper uses cell phenotype rescue and caspase-6 activity assays.",
                    "judgment": "Yes",
                    "reasoning": "Both cell phenotype rescue and caspase-6 activity assays are commonly used in the field to study protein function, proteolytic activity, and their role in disease pathogenesis."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "sub_steps": [
                        {
                            "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
                            "questions": [
                                {
                                    "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                                    "answer": "Yes"
                                },
                                {
                                    "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
                            "questions": [
                                {
                                    "question": "Has the specific instance of the assay been broadly accepted historically? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                                    "answer": "Not applicable"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3c: Variant Controls",
                            "questions": [
                                {
                                    "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4a: Statistical Analyses",
                            "questions": [
                                {
                                    "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4b: No OddsPath Calculation",
                            "questions": [
                                {
                                    "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                                    "answer": "At least 11"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4c: Correlate OddsPath",
                            "questions": [
                                {
                                    "question": "Is there an explicit OddsPath value given for this variant?",
                                    "answer": "No"
                                }
                            ]
                        }
                    ]
                }
            ],
            "functional_evidence_strength": "Max PS3_moderate"
        },
        {
            "variant_id": {
                "Gene": "DJ-1",
                "Protein_Change": {
                    "ref": "L",
                    "alt": "P"
                },
                "variant_string_id": "DJ-1 LP"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper discusses the loss of function of DJ-1 in Parkinson’s disease due to proteolytic resistance to caspase-6.",
                    "judgment": "Yes",
                    "reasoning": "DJ-1 is a gene product responsible for a subset of familial PD, and the mechanisms by which mutations alter its function and account for PD-related pathology are investigated."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The paper uses cell phenotype rescue and caspase-6 activity assays.",
                    "judgment": "Yes",
                    "reasoning": "Both cell phenotype rescue and caspase-6 activity assays are commonly used in the field to study protein function, proteolytic activity, and their role in disease pathogenesis."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "sub_steps": [
                        {
                            "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
                            "questions": [
                                {
                                    "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                                    "answer": "Yes"
                                },
                                {
                                    "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
                            "questions": [
                                {
                                    "question": "Has the specific instance of the assay been broadly accepted historically? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                                    "answer": "Not applicable"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3c: Variant Controls",
                            "questions": [
                                {
                                    "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4a: Statistical Analyses",
                            "questions": [
                                {
                                    "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4b: No OddsPath Calculation",
                            "questions": [
                                {
                                    "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                                    "answer": "At least 11"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4c: Correlate OddsPath",
                            "questions": [
                                {
                                    "question": "Is there an explicit OddsPath value given for this variant?",
                                    "answer": "No"
                                }
                            ]
                        }
                    ]
                }
            ],
            "functional_evidence_strength": "Max PS3_supporting"
        },
        {
            "variant_id": {
                "Gene": "DJ-1",
                "Protein_Change": {
                    "ref": "L",
                    "alt": "B"
                },
                "variant_string_id": "DJ-1 LB"
            },
            "functional_evidence_aim": "Benign",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper discusses the loss of function of DJ-1 in Parkinson’s disease due to proteolytic resistance to caspase-6.",
                    "judgment": "No",
                    "reasoning": "A benign variant would not be expected to contribute to the development or progression of PD, as it does not affect the protein's function related to proteolytic resistance to caspase-6."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The paper uses cell phenotype rescue and caspase-6 activity assays.",
                    "judgment": "Yes",
                    "reasoning": "Both cell phenotype rescue and caspase-6 activity assays are commonly used in the field to study protein function, proteolytic activity, and their role in disease pathogenesis. However, they may not be appropriate for assessing benign variants if the assay outcomes are predominantly related to loss of function or altered proteolytic activity."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "sub_steps": [
                        {
                            "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
                            "questions": [
                                {
                                    "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                                    "answer": "Yes"
                                },
                                {
                                    "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3b: Accepted/Validated Assay",
                            "questions": [
                                {
                                    "question": "Has the specific instance of the assay been broadly accepted historically? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                                    "answer": "Not applicable"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 3c: Variant Controls",
                            "questions": [
                                {
                                    "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls? OR Were variants tested that reach P/LP (Pathogenic/Likely Pathogenic) or B/LB (Benign/Likely Benign) criteria without relying on PS3/BS3 evidence themselves?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4a: Statistical Analyses",
                            "questions": [
                                {
                                    "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                                    "answer": "No"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4b: No OddsPath Calculation",
                            "questions": [
                                {
                                    "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                                    "answer": "At least 11"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "Sub-step 4c: Correlate OddsPath",
                            "questions": [
                                {
                                    "question": "Is there an explicit OddsPath value given for this variant?",
                                    "answer": "No"
                                }
                            ]
                        }
                    ]
                }
            ],
            "functional_evidence_strength": "Not applicable"
        }
    ]